222 related articles for article (PubMed ID: 22750193)
1. Transcutaneous vaccination via laser microporation.
Weiss R; Hessenberger M; Kitzmüller S; Bach D; Weinberger EE; Krautgartner WD; Hauser-Kronberger C; Malissen B; Boehler C; Kalia YN; Thalhamer J; Scheiblhofer S
J Control Release; 2012 Sep; 162(2):391-9. PubMed ID: 22750193
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
[TBL] [Abstract][Full Text] [Related]
3. Application of water-soluble polyvinyl alcohol-based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery.
Engelke L; Winter G; Engert J
Eur J Pharm Biopharm; 2018 Jul; 128():119-130. PubMed ID: 29660407
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado Y; Duinkerken S; Hoepflinger V; Mayr M; Korotchenko E; Kurtaj A; Pablos I; Steiner M; Stoecklinger A; Lübbers J; Schmid M; Ritter U; Scheiblhofer S; Ablinger M; Wally V; Hochmann S; Raninger AM; Strunk D; van Kooyk Y; Thalhamer J; Weiss R
J Control Release; 2017 Nov; 266():87-99. PubMed ID: 28919557
[TBL] [Abstract][Full Text] [Related]
5. Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.
Bach D; Weiss R; Hessenberger M; Kitzmueller S; Weinberger EE; Krautgartner WD; Hauser-Kronberger C; Boehler C; Thalhamer J; Scheiblhofer S
Allergy; 2012 Nov; 67(11):1365-74. PubMed ID: 22947064
[TBL] [Abstract][Full Text] [Related]
6. Micro-fractional epidermal powder delivery for improved skin vaccination.
Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
[TBL] [Abstract][Full Text] [Related]
7. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
8. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
9. Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.
Scheiblhofer S; Thalhamer J; Weiss R
Expert Opin Drug Deliv; 2013 Jun; 10(6):761-73. PubMed ID: 23425032
[TBL] [Abstract][Full Text] [Related]
10. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
[TBL] [Abstract][Full Text] [Related]
11. Parameter optimization toward optimal microneedle-based dermal vaccination.
van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
[TBL] [Abstract][Full Text] [Related]
12. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.
Kumar A; Li X; Sandoval MA; Rodriguez BL; Sloat BR; Cui Z
Int J Nanomedicine; 2011; 6():1253-64. PubMed ID: 21753877
[TBL] [Abstract][Full Text] [Related]
13. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
[TBL] [Abstract][Full Text] [Related]
15. Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.
Chen X; Shah D; Kositratna G; Manstein D; Anderson RR; Wu MX
J Control Release; 2012 Apr; 159(1):43-51. PubMed ID: 22261281
[TBL] [Abstract][Full Text] [Related]
16. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
[TBL] [Abstract][Full Text] [Related]
18. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
Bachhav YG; Heinrich A; Kalia YN
Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticulate mediated transcutaneous immunization: Myth or reality.
Kaurav M; Minz S; Sahu K; Kumar M; Madan J; Pandey RS
Nanomedicine; 2016 May; 12(4):1063-1081. PubMed ID: 26767517
[TBL] [Abstract][Full Text] [Related]
20. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
Bachhav YG; Summer S; Heinrich A; Bragagna T; Böhler C; Kalia YN
J Control Release; 2010 Aug; 146(1):31-6. PubMed ID: 20678988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
